beta
/LBA75 Sevabertinib (BAY 2927088) in advanced HER2-mutant non-small cell lung cancer (NSCLC): Results from the SOHO-01 study
Abstract

Abstract N/A

RelatedView All
CitationsView All
Citing-
Cited By-